FGK Clinical Research s.r.o
FGK Clinical Research s.r.o is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Pivotal, Randomized, Placebo-Controlled, Double-Blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)
Sponsor Rheacell GmbH & Co. KG
- Start (EU)
- Latest update
- Estimated end
Efficacy of Vitex agnus-castus BNO 1095 (20 mg) in women with primary dysmenorrhea
Sponsor Bionorica SE
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for FGK Clinical Research s.r.o?
The 2026-10-09 snapshot links FGK Clinical Research s.r.o to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for FGK Clinical Research s.r.o?
The most frequently recorded therapeutic areas are Dermatology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to FGK Clinical Research s.r.o conducted?
The linked trials record locations in 10 countries, including Austria, Czechia, Germany, Hungary, Poland. These are trial locations, not confirmed office locations or countries where FGK Clinical Research s.r.o delivered services.
What can this page tell me about FGK Clinical Research s.r.o's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under FGK Clinical Research s.r.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- FGK Clinical Research s.r.o.